DNMT3A and renal cell carcinoma: LncRNA SLERCC (Specific Low Expression in RCC) is lowly expressed in renal cell carcinoma via DNMT3A-mediated SLERCC promoter hypermethylation and its overexpression inhibits Wnt/β-catenin signaling and RCC metastasis.